USMAN IQBAL, Chief Medical Officer, Julz Pharma

•   Usman Iqbal MD, MPH, MBA is the Chief Medical Officer at Julz Pharma. He is a medical executive with a portfolio career entailing 15 + years of diverse experience spanning R&D, Medical Affairs, Value and Access across both large and small cap biopharmaceuticals. His experience spans a number of therapeutic areas including Neuroscience, as the Senior Medical Affairs Leader at AstraZeneca Innovative Medicines Group (IMG), and in Oncology, as former Head of Sanofi Oncology, Global Evidence & Value Development (GEVD). With positions of increasing responsibilities across both R&D and Medical Affairs in different organizations, Dr. Iqbal has successfully led several development programs with a strategic focus on innovation, operational excellence, and end in mind approach driven by medical value and patient centricity.

•   As a medical leader, he has led numerous organizational transformations, built integrated and transversal medical platforms, and led the execution of integrated Medical Affairs strategy for several launched products. His area of expertise also includes harnessing big data science, real world evidence, advanced analytics and digital medicine to optimize R&D portfolios, Trial designs, Medical Affairs delivery and Patient Access. Prior to working in the industry that also includes Amgen, Trevena, and Acer Therapeutics, Dr. Iqbal was at the Boston University Health Outcomes Technology Group where he served as a senior research fellow at the Center for Assessment of Pharmaceutical Practices (CAPPs) and Veterans Affairs Pharmacy Benefit Management (VA-PBM).

•   Dr. Iqbal has authored 50+ publications and serves as an industry consultant & thought leader on “end to end” clinical asset development, evidence & value generation, and 3P (physician, patient, payer) driven integrated medical affairs operating models. He received his MD from Allama Iqbal Medical College, Lahore, Pakistan and MPH and MBA degrees from Boston University.